Sydney Towle is sharing her cancer journey on social media as a way to connect with and help others. She's currently waiting ...

In February 2024, the FDA put two Phase II studies of zelnecirnon under a clinical hold after a case of liver failure was deemed potentially related to the drug.

RAPT Therapeutics stock falls after halting its zelnecirnon program following FDA clinical hold. Company shifts focus.

Pharma Two B Ltd. (“Pharma Two B”), a late-clinical stage company that is developing P2B001, an innovative combination product candidate for the treatment of Parkinson’s Disease (“PD”) and Hepion ...

CytoSorbents is renowned for its flagship product, CytoSorb ®, a blood purification technology that reduces "cytokine storm” ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today ...

The Dirty Dancing star would have marked his 72nd birthday in 2024, but he sadly passed away in 2009 at the age of 57 after a ...

In recent years, non-alcoholic fatty liver disease (NAFLD) has developed rapidly worldwide and has become the main cause of chronic liver disease. With the increase in prevalence, the incidence of ...

clinicians often consider discontinuing DMTs when patients reach this stage of the disease to reduce treatment burden, such as increased risk of infection and liver or kidney impairment associated ...

Old pill, new tricks? Research suggests that an old drug called finasteride reduce heart disease risk on top of regrowing ...

Lenvatinib/pembrolizumab certainly provides an alternative treatment that we propose as a frontline option for patients with intermediate HCC, which represents 30% of patients and includes those with ...